WASHINGTON (AP) — The government on Tuesday lowered to 15 the age at which girls can buy the morning-after pill without a prescription and said the emergency contraception no longer has to be kept behind pharmacy counters.
The decision by the Food and Drug Administration is an attempt to find middle ground just days before a court-imposed deadline to lift all age restrictions on the drug. Read More
TULSA, Okla. (AP) — Health officials on Thursday urged thousands of patients of an Oklahoma oral surgeon to undergo hepatitis and HIV testing, saying unsanitary conditions behind his office's spiffy facade posed a threat to his clients and made him a "menace to the public health." Read More
Is America still a place where big ideas can move policymakers to slash red tape in drug development to save lives, drive innovation and spur economic growth?It certainly appears so. The Obama administration, industry, the Food and Drug Administration and patients’ groups have all come together in recent months to highlight the need for regulatory reforms to help patients gain faster access to safer and more innovative medicines. Read More
Few chemicals have generated the controversy of bisphenol A, a building block for certain plastics and food can liners. The controversy continues in spite of recent studies which show that human exposures to BPA are far below levels that have been shown to cause adverse effects in animals. Read More
Last week at a meeting of the American Society of Clinical Oncology, ASCO President George Sledge painted a hopeful, but also challenging, picture about new genomic technologies for fighting cancer. These technologies can unravel the genetic mechanisms driving the disease and point the way to new strategies to overcome cancer-drug resistance. Read More
→ Follow Nate Beeler on Twitter
→ Nate Beeler's Editorial Cartoons on Facebook
→ Get Nate Beeler's cartoons sent to your e- Read More
When it comes to the newest and most-advanced medical devices, Europe is getting them first, according to a new study by a group of researchers at Northwestern University in Chicago. Read More
(Editor's note: The following article was written prior to the State of the Union address.) Read More
On Dec. 16, the Food and Drug Administration made a decision that could cause thousands of breast cancer patients to lose their last hope. That day, officials voted to revoke approval for Avastin for the treatment of late-stage breast cancer.
This move is a disgrace. Read More
Today is D-Day for breast cancer patients. The Food and Drug Administration is expected to announce whether it will rescind approval of Avastin for the treatment of late-stage breast cancer.If the FDA denies Avastin, the agency will be allowing politics to trump good medicine.Avastin is a cutting-edge drug that staves off cancer by cutting off blood supply to tumors. For thousands of women, it is a miracle treatment. Read More